JPMorgan Expects a Strong Medtronic, Inc. (MDT) Report on Thursday BMO

May 19, 2021 6:26 AM EDT Send to a Friend
JPMorgan analyst Robbie Marcus reiterated an Overweight rating and $130.00 price target on Medtronic, Inc. (NYSE: MDT) noting that management ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login